FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for neurodegenerative diseases treatment comprises choline alphoscerate in an amount of 30-70 wt %, at least one solvent being purified water or water with ethyl alcohol and auxiliary substances. The pharmaceutical composition of choline alphosherate is in the form of a spray for oral administration. A medicament comprising the said composition is also described.
EFFECT: advantages of the new dosage form of choline alfoscerate are improved bioavailability compared to oral forms, storage stability and ease of use caused by a compact vial with a spray dispenser.
2 cl, 6 tbl, 6 ex
Authors
Dates
2017-10-09—Published
2015-12-25—Filed